Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease
David J. Cohen, Ruben L.J. Osnabrugge, Elizabeth A. Magnuson, Kaijun Wang, Haiyan Li, Khaja Chinnakondepalli, Duane S. Pinto, Mouin Abdallah, Katherine A. Vilain, Marie‐Claude Morice, Keith D. Dawkins, A. Pieter Kappetein, Friedrich W. Mohr, Patrick W. Serruys (2014). Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease. Circulation, 130(14), pp. 1146-1157, DOI: 10.1161/circulationaha.114.009985.
Article288 days agoQuality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease
Mouin Abdallah, Kaijun Wang, Elizabeth A. Magnuson, Ruben L.J. Osnabrugge, A. Pieter Kappetein, Marie‐Claude Morice, Friedrich Mohr, Patrick W. Serruys, David J. Cohen (2017). Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease. Journal of the American College of Cardiology, 69(16), pp. 2039-2050, DOI: 10.1016/j.jacc.2017.02.031.
Article288 days agoEconomic outcomes of percutaneous coronary intervention with drug‐eluting stents versus bypass surgery for patients with left main or three‐vessel coronary artery disease: One‐year results from the SYNTAX trial
David J. Cohen, Tara A. Lavelle, Ben van Hout, Haiyan Li, Yang Lei, Katherine Robertus, Duane S. Pinto, Elizabeth A. Magnuson, Thomas McGarry, Scott K. Lucas, Phillip A. Horwitz, Carl A. Henry, Patrick W. Serruys, Friedrich W. Mohr, A. Pieter Kappetein (2011). Economic outcomes of percutaneous coronary intervention with drug‐eluting stents versus bypass surgery for patients with left main or three‐vessel coronary artery disease: One‐year results from the SYNTAX trial. Catheterization and Cardiovascular Interventions, 79(2), pp. 198-209, DOI: 10.1002/ccd.23147.
Article288 days agoDo Differences in Repeat Revascularization Explain the Antianginal Benefits of Bypass Surgery Versus Percutaneous Coronary Intervention?
Suzanne V. Arnold, Elizabeth A. Magnuson, Kaijun Wang, Patrick W. Serruys, A. Pieter Kappetein, Friedrich W. Mohr, David J. Cohen (2012). Do Differences in Repeat Revascularization Explain the Antianginal Benefits of Bypass Surgery Versus Percutaneous Coronary Intervention?. Circulation Cardiovascular Quality and Outcomes, 5(3), pp. 267-275, DOI: 10.1161/circoutcomes.111.964585.
Article288 days agoCost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective
Ruben L.J. Osnabrugge, Elizabeth A. Magnuson, Patrick W. Serruys, Carlos M. Campos, Kaijun Wang, David van Klaveren, Vasim Farooq, Mouin Abdallah, Haiyan Li, Katherine A. Vilain, Ewout W. Steyerberg, Marie‐Claude Morice, Keith D. Dawkins, Friedrich W. Mohr, A. Pieter Kappetein, David J. Cohen (2015). Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective. Heart, 101(24), pp. 1980-1988, DOI: 10.1136/heartjnl-2015-307578.
Article288 days ago